← back to search

Yukihiko Hiroshima

Kanagawa Prefectural Hospital Organization · JP
Area of research
Biotechnology · Biomedical Engineering
Research interest
Research interests include Cancer Research and Treatments, Nanoplatforms for cancer theranostics, Virus-based gene therapy research, and Pancreatic and Hepatic Oncology Research.
h-index
35
citations
4,072
works
241
NIH funding
primary concept
email

Recent publications

Overexpression of Nuclear Factor of Activated T-cells (NFAT) Transcription Factors Drives Chemoresistance and Poor Outcomes in Pancreatic Cancer.
2025cited by 1position: contributordoi
Preliminary Screening for Hereditary Breast and Ovarian Cancer Using an AI Chatbot as a Genetic Counselor: Clinical Study.
2024cited by 7position: contributordoi
Role of the tumor microenvironment in pancreatic cancer
Annals of Gastroenterological Surgery 2019cited by 181position: middledoi
Recombinant methioninase effectively targets a Ewing's sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse model
Oncotarget 2017cited by 81position: middledoi
The combination of temozolomide-irinotecan regresses a doxorubicin-resistant patient-derived orthotopic xenograft (PDOX) nude-mouse model of recurrent Ewing’s sarcoma with a FUS-ERG fusion and <i>CDKN2A</i> deletion: Direction for third-line patient therapy
Oncotarget 2017cited by 41position: middledoi
The irony of highly-effective bacterial therapy of a patient-derived orthotopic xenograft (PDOX) model of Ewing's sarcoma, which was blocked by Ewing himself 80 years ago
Cell Cycle 2017cited by 38position: middledoi
Tumor-targeting <i>Salmonella typhimurium</i> A1-R in combination with doxorubicin eradicate soft tissue sarcoma in a patient-derived orthotopic xenograft (PDOX) model
Oncotarget 2016cited by 116position: middledoi
Efficacy of Tumor-Targeting Salmonella A1-R on a Melanoma Patient-Derived Orthotopic Xenograft (PDOX) Nude-Mouse Model
PLoS ONE 2016cited by 102position: middledoi
Effective molecular targeting of CDK4/6 and IGF-1R in a rare <i>FUS-ERG</i> fusion <i>CDKN2A</i>-deletion doxorubicin-resistant Ewing's sarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse model
Oncotarget 2016cited by 97position: middledoi
Patient-derived mouse models of cancer need to be orthotopic in order to evaluate targeted anti-metastatic therapy
Oncotarget 2016cited by 61position: firstdoi
Tumor-targeting Salmonella typhimurium A1-R regresses an osteosarcoma in a patient-derived xenograft model resistant to a molecular-targeting drug
Oncotarget 2016cited by 55position: middledoi
Establishment of a Patient-Derived Orthotopic Xenograft (PDOX) Model of HER-2-Positive Cervical Cancer Expressing the Clinical Metastatic Pattern
PLoS ONE 2015cited by 112position: firstdoi
Tumor-Targeting Salmonella typhimurium A1-R Arrests a Chemo-Resistant Patient Soft-Tissue Sarcoma in Nude Mice
PLoS ONE 2015cited by 83position: firstdoi
Patient-derived orthotopic xenograft (PDOX) nude mouse model of soft-tissue sarcoma more closely mimics the patient behavior in contrast to the subcutaneous ectopic model.
PubMed 2015cited by 73position: first
Near Infra-Red Photoimmunotherapy with Anti-CEA-IR700 Results in Extensive Tumor Lysis and a Significant Decrease in Tumor Burden in Orthotopic Mouse Models of Pancreatic Cancer
PLoS ONE 2015cited by 68position: middledoi
Intraperitoneal administration of tumor-targeting <i>Salmonella typhimurium</i> A1-R inhibits disseminated human ovarian cancer and extends survival in nude mice
Oncotarget 2015cited by 59position: middledoi
Tumor-Targeting Salmonella typhimurium A1-R in Combination with Trastuzumab Eradicates HER-2-Positive Cervical Cancer Cells in Patient-Derived Mouse Models
PLoS ONE 2015cited by 54position: firstdoi
Efficacy of tumor-targeting <i>Salmonella typhimurium</i> A1-R in combination with anti-angiogenesis therapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX) and cell line mouse models
Oncotarget 2014cited by 129position: firstdoi
Successful Fluorescence-Guided Surgery on Human Colon Cancer Patient-Derived Orthotopic Xenograft Mouse Models Using a Fluorophore-Conjugated Anti-CEA Antibody and a Portable Imaging System
Journal of Laparoendoscopic & Advanced Surgical Techniques 2014cited by 124position: firstdoi
Tumor-targeting <i>Salmonella typhimurium</i> A1-R decoys quiescent cancer cells to cycle as visualized by FUCCI imaging and become sensitive to chemotherapy
Cell Cycle 2014cited by 104position: middledoi
Efficacy of <i>Salmonella typhimurium</i> A1‐R Versus Chemotherapy on a Pancreatic Cancer Patient‐Derived Orthotopic Xenograft (PDOX)
Journal of Cellular Biochemistry 2014cited by 102position: firstdoi
Metastatic Recurrence in a Pancreatic Cancer Patient Derived Orthotopic Xenograft (PDOX) Nude Mouse Model Is Inhibited by Neoadjuvant Chemotherapy in Combination with Fluorescence-Guided Surgery with an Anti-CA 19-9-Conjugated Fluorophore
PLoS ONE 2014cited by 91position: firstdoi
Invading cancer cells are predominantly in G<sub>0</sub>/G<sub>1</sub>resulting in chemoresistance demonstrated by real-time FUCCI imaging
Cell Cycle 2014cited by 79position: middledoi
Selective efficacy of zoledronic acid on metastasis in a patient‐derived orthotopic xenograph (PDOX) nude‐mouse model of human pancreatic cancer
Journal of Surgical Oncology 2014cited by 77position: firstdoi
Spatial–temporal FUCCI imaging of each cell in a tumor demonstrates locational dependence of cell cycle dynamics and chemoresponsiveness
Cell Cycle 2014cited by 77position: middledoi
Efficacy of tumor-targeting<i>Salmonella typhimurium</i>A1-R on nude mouse models of metastatic and disseminated human ovarian cancer
Journal of Cellular Biochemistry 2014cited by 53position: middledoi
Comparison of efficacy of<i>Salmonella typhimurium</i>A1-R and chemotherapy on stem-like and non-stem human pancreatic cancer cells
Cell Cycle 2013cited by 79position: firstdoi
Hand-held high-resolution fluorescence imaging system for fluorescence-guided surgery of patient and cell-line pancreatic tumors growing orthotopically in nude mice
Journal of Surgical Research 2013cited by 73position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Robert M. Hoffman · University of California, Los Angeles26 papers (2013–2019)Michael Bouvet · University of California, Los Angeles24 papers (2013–2017)Itaru Endo · The Ohio State University19 papers (2013–2019) · 17 papers (2013–2017)Takashi Murakami · Independent Administrative Institution National Research Institute for Cultural Properties16 papers (2013–2019) · 16 papers (2013–2017)Yong Zhang · Zaozhuang University16 papers (2013–2016)Shinji Miwa · Kanazawa University14 papers (2013–2015)Fuminari Uehara · Tosoh (Japan)13 papers (2013–2015)Ali Maawy · Roswell Park Comprehensive Cancer Center13 papers (2013–2016)Shuya Yano · Kawasaki Medical School13 papers (2013–2015)Ming Zhao · Shanxi Provincial Cancer Hospital13 papers (2013–2017)Masashi Momiyama · NTT Medical Center11 papers (2013–2017)Ryusei Matsuyama · Roswell Park Comprehensive Cancer Center10 papers (2014–2019)Mako Yamamoto · Gifu University10 papers (2014–2016) · 7 papers (2014–2016)Fritz C. Eilber · APLA Health7 papers (2016–2017)Arun S. Singh · University of Santa Monica6 papers (2016–2017)Tasuku Kiyuna · Funabashi Orthopaedic Hospital5 papers (2016–2017)Sumiyuki Mii · Kitasato University5 papers (2014–2015)